Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1977 1
1979 1
1984 2
1985 1
1988 1
1989 1
1991 1
1993 2
1995 1
1996 5
1997 3
1998 6
1999 3
2000 2
2001 6
2002 4
2003 3
2005 1
2006 5
2007 5
2008 4
2009 7
2010 5
2011 10
2012 3
2013 4
2014 11
2015 11
2016 13
2017 13
2018 23
2019 14
2020 21
2021 48
2022 44
2023 40
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Results by year

Filters applied: . Clear all
Page 1
Breast Cancer Genetics: Diagnostics and Treatment.
Criscitiello C, Corti C. Criscitiello C, et al. Among authors: corti c. Genes (Basel). 2022 Sep 6;13(9):1593. doi: 10.3390/genes13091593. Genes (Basel). 2022. PMID: 36140761 Free PMC article.
Antibody-drug conjugates: Smart chemotherapy delivery across tumor histologies.
Tarantino P, Carmagnani Pestana R, Corti C, Modi S, Bardia A, Tolaney SM, Cortes J, Soria JC, Curigliano G. Tarantino P, et al. Among authors: corti c. CA Cancer J Clin. 2022 Mar;72(2):165-182. doi: 10.3322/caac.21705. Epub 2021 Nov 12. CA Cancer J Clin. 2022. PMID: 34767258 Free article. Review.
Bystander effect of antibody-drug conjugates: fact or fiction?
Giugliano F, Corti C, Tarantino P, Michelini F, Curigliano G. Giugliano F, et al. Among authors: corti c. Curr Oncol Rep. 2022 Jul;24(7):809-817. doi: 10.1007/s11912-022-01266-4. Epub 2022 Mar 19. Curr Oncol Rep. 2022. PMID: 35305211 Review.
HER2-Low Breast Cancer: a New Subtype?
Corti C, Giugliano F, Nicolò E, Tarantino P, Criscitiello C, Curigliano G. Corti C, et al. Curr Treat Options Oncol. 2023 May;24(5):468-478. doi: 10.1007/s11864-023-01068-1. Epub 2023 Mar 27. Curr Treat Options Oncol. 2023. PMID: 36971965 Review.
Targeting brain metastases in breast cancer.
Corti C, Antonarelli G, Criscitiello C, Lin NU, Carey LA, Cortés J, Poortmans P, Curigliano G. Corti C, et al. Cancer Treat Rev. 2022 Feb;103:102324. doi: 10.1016/j.ctrv.2021.102324. Epub 2021 Dec 16. Cancer Treat Rev. 2022. PMID: 34953200 Review.
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Bhatnagar N, Annane D, Reinhart K, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Lima SS, Maravić-Stojković V, Verduri A, Cao B, Shehabi Y, Beishuizen A, Jensen JS, Corti C, Van Oers JA, Falsey AR, de Jong E, Oliveira CF, Beghe B, Briel M, Mueller B. Schuetz P, et al. Among authors: corti c. Cochrane Database Syst Rev. 2017 Oct 12;10(10):CD007498. doi: 10.1002/14651858.CD007498.pub3. Cochrane Database Syst Rev. 2017. PMID: 29025194 Free PMC article. Review.
301 results